GPD Antibodies

Santa Cruz Biotechnology delivers a wide array of GPD Antibodies for research focused on glycerol-3-phosphate dehydrogenase (GPD) functions. GPD Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Glycerol-3-phosphate dehydrogenase plays a crucial role in cellular metabolism, particularly in the conversion of glycerol-3-phosphate to dihydroxyacetone phosphate, linking lipid and carbohydrate metabolism. The enzyme is essential for energy production and is involved in the regulation of metabolic pathways, making it a significant target for studies related to metabolic disorders and energy homeostasis. Understanding GPD function is vital for advancing research in various fields, including diabetes and obesity. Research capabilities can be enhanced through detailed investigation of metabolic processes governed by glycerol-3-phosphate dehydrogenase. GPD monoclonal antibodies enable precise detection and analysis of enzyme activity in metabolic studies. Researchers exploring cellular metabolism and energy pathways can rely on GPD monoclonal antibodies from Santa Cruz Biotechnology to advance scientific understanding of metabolic disorders.